← Back to Clinical Trials
Recruiting NCT06182111

NCT06182111 Intraoperative Administration of Intravenous Morphine in Patients Undergoing Laparoscopic Cholecystectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06182111
Status Recruiting
Phase
Sponsor Esbjerg Hospital - University Hospital of Southern Denmark
Condition Postoperative Pain
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2024-06-01
Primary Completion 2025-05-31

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Intraoperative morphine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2024-06-01 with a primary completion date of 2025-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational, quality improvement study is to compare the effect of a dose of morphine given during gall-bladder removal surgery. The main questions to answer are: * Do participants, who are given given a dose of morphine during gall-bladder removal surgery, experience less pain after surgery? * Does a dose of morphine during gall-bladder removal surgery cause more side effects? The investigators will compare the effects of two types of anesthesia: a) anesthesia without morphine during surgery, and b) anesthesia with morphine during surgery.

Eligibility Criteria

Inclusion Criteria: * patients who have had elective laparoscopic cholecystectomy/planned gall-bladder removal surgery Exclusion Criteria: * age limit as above * patients unable to give consent to anesthesia * patients unable to participate in pain scoring * patients with chronic pain syndromes, characterized by patients receiving regular analgesic treatment and patients with active or previous contact to pain clinic) * patients with active or previous substance abuse * emergency surgery

Contact & Investigator

Central Contact

Sanne V Nielsen, MD

✉ sanne.vibe.nielsen@rsyd.dk

📞 +45 28 49 18 25 (private)

Principal Investigator

Sanne V Nielsen, MD

PRINCIPAL INVESTIGATOR

Esbjerg Hospital - University Hospital of Southern Denmark

Frequently Asked Questions

Who can join the NCT06182111 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06182111 currently recruiting?

Yes, NCT06182111 is actively recruiting participants. Contact the research team at sanne.vibe.nielsen@rsyd.dk for enrollment information.

Where is the NCT06182111 trial being conducted?

This trial is being conducted at Esbjerg, Denmark.

Who is sponsoring the NCT06182111 clinical trial?

NCT06182111 is sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. The principal investigator is Sanne V Nielsen, MD at Esbjerg Hospital - University Hospital of Southern Denmark. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology